Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
Surufatinib Plus Camrelizumab and AS in First Line Treatment of Advanced Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Adavosertib and Gemcitabine in Advanced Pancreatic
- Status
- WITHDRAWN
- Phase
- PHASE2
Pharmacotyping of Pancreatic Patient-derived Organoids
- Status
- RECRUITING
- Phase
- N/A
Pancreatic Cancer Evolution Upon Treatment
- Status
- RECRUITING
- Phase
- NA
Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases
- Status
- RECRUITING
- Phase
- N/A
New Onset Diabetes Management for Earlier Detection of Pancreatic Cancer (NODMED)
- Status
- TERMINATED
- Phase
- NA
EpiDetect Study: Clinical Validation of a Pancreatic Cancer Detection Test in New-Onset Diabetes Patients
- Status
- WITHDRAWN
- Phase
- NA
Registry for Advanced Endoscopy
- Status
- RECRUITING
- Phase
- N/A
SHR6390 Plus Nab-paclitaxel and Gemcitabine in Advanced/Metastatic Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
- Status
- RECRUITING
- Phase
- N/A
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
- Status
- RECRUITING
- Phase
- PHASE1
Radiation Therapy (RT) and Chemotherapy for the Treatment of Pancreatic Cancer with Homologous Recombination Deficiency That Has Spread to the Liver
- Status
- COMPLETED
- Phase
- PHASE1
Tempus Priority Study: A Pan-tumor Observational Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
- Status
- TERMINATED
- Phase
- PHASE2
The First Line Treatment of Fruquintinib Combined With Albumin Paclitaxel and Gemcitabine in Pancreatic Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1